Search

Tandem Diabetes Care Inc

Closed

SectorHealthcare

21.28 -0.33

Overview

Share price change

24h

Current

Min

21

Max

21.57

Key metrics

By Trading Economics

Income

-775K

-21M

Sales

7.3M

255M

EPS

-0.31

Profit margin

-8.316

Employees

2,500

EBITDA

4.5M

-9.2M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+22.8% upside

Dividends

By Acuity

Next Earnings

5 lis 2026

Market Stats

By TradingEconomics

Market Cap

175M

1.6B

Previous open

21.61

Previous close

21.28

News Sentiment

By Acuity

50%

50%

160 / 340 Ranking in Healthcare

Tandem Diabetes Care Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

25 sie 2026, 20:07 UTC

Tandem Diabetes Care shares are lower today, continuing a trend of five consecutive daily declines. Earlier, the stock reached a session high before pulling back.

24 sie 2026, 19:36 UTC

News

Tandem Diabetes Care shares are lower today, following a downward trend since Friday. Analysts maintain a "Hold" consensus, with targets ranging from $18 to $40.

21 sie 2026, 19:46 UTC

Tandem Diabetes Care Inc. shares are roughly flat today, showing some volatility with a high of 2.13% and a low of -2.80%.

20 sie 2026, 20:02 UTC

Tandem Diabetes Care Inc shares are lower amid broader market pressures following Walmart Inc's disappointing earnings report, raising concerns about consumer spending.

19 sie 2026, 19:46 UTC

Tandem Diabetes Care Inc. shares are higher, reflecting routine performance amid a broader rebound in stock prices linked to declining bond yields.

18 sie 2026, 20:01 UTC

Tandem Diabetes Care is trading higher today, reflecting strong intraday performance despite recent lower finishes. The stock remains above its 20-day moving average.

17 sie 2026, 19:46 UTC

News

Tandem Diabetes Care shares are lower as investor caution follows its Q2 earnings report, despite meeting revenue and profit expectations.

14 sie 2026, 20:06 UTC

Tandem Diabetes Care shares are lower today amid economic concerns following a disappointing U.S. retail sales report for July. The stock remains above its 20-day moving average.

13 sie 2026, 19:16 UTC

Tandem Diabetes Care shares are trading lower today, despite broader market support and an early high. Initial jobless claims rose, indicating potential labor market softening.

12 sie 2026, 19:41 UTC

News

Tandem Diabetes Care reported a narrower second-quarter loss of 31 cents per share, with revenues of $254.6 million, as shares rise since Tuesday.

11 sie 2026, 19:46 UTC

News

Tandem Diabetes Care reported improved second-quarter results, including a narrower loss and increased revenue, supporting shares' advance during Tuesday's session.

10 sie 2026, 19:36 UTC

News

Tandem Diabetes Care reported second-quarter revenue of $254.6 million and reaffirmed its full-year guidance of $1.08 billion, supporting a higher share price today.

7 sie 2026, 20:02 UTC

News

Tandem Diabetes Care shares rose after Q2 sales of $254.6 million and adjusted EBITDA of $6.4 million exceeded forecasts, despite RBC lowering its price target to $26.

6 sie 2026, 23:02 UTC

News

Tandem Diabetes Care reported Q2 sales of $254.6 million and reaffirmed revenue guidance, with shares trading higher in after-market hours.

5 sie 2026, 19:56 UTC

News

Tandem Diabetes Care Inc's shares are declining amid negative sentiment in the insulin sector following Insulet Corp's lowered revenue growth forecast.

4 sie 2026, 19:46 UTC

Tandem Diabetes Care Inc shares are lower today, influenced by declines in the Health Care Equipment sub-sector. Earlier, the stock reached a session high before pulling back.

31 lip 2026, 19:51 UTC

Tandem Diabetes Care Inc is advancing today, benefiting from positive market sentiment driven by technology stocks, despite pulling back from earlier session highs.

30 lip 2026, 17:11 UTC

Tandem Diabetes Care shares are lower today as the Health Care Equipment sub-sector declines. The asset remains above its 20-day moving average.

29 lip 2026, 18:15 UTC

Tandem Diabetes Care Inc. shares are higher, driven by significant gains in Health Care Equipment stocks, despite a recent trend of daily price increases.

27 lip 2026, 19:21 UTC

Tandem Diabetes Care Inc. shares are lower, reflecting broader market trends amid declining oil prices and easing geopolitical tensions ahead of the Federal Reserve meeting.

24 lip 2026, 14:02 UTC

Tandem Diabetes Care Inc shares are lower today, with no specific news identified. Broader market concerns follow a significant sell-off on Thursday.

21 lip 2026, 19:06 UTC

Tandem Diabetes Care is lower today, driven by declines in the Health Care Equipment sub-sector. The asset has fallen steadily after an early high.

20 lip 2026, 17:26 UTC

Tandem Diabetes Care Inc shares are higher today, recovering from an early dip. The stock has gained significantly since last month’s close.

Peer Comparison

Price change

Tandem Diabetes Care Inc Forecast

Price Target

By TipRanks

22.8% upside

12 Months Forecast

Average 26.5 USD  22.8%

High 50 USD

Low 15.5 USD

Based on 16 Wall Street analysts offering 12 month price targets forTandem Diabetes Care Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

16 ratings

9

Buy

7

Hold

0

Sell

Sentiment

By Acuity

160 / 340 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Tandem Diabetes Care Inc

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. It has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
help-icon Live chat